May 28, 2004 -- A buccal testosterone delivery system is superior to the transdermal system, according to the results of a randomized trial published in the May issue of the Journal of Clinical ...

Please provide your email address to receive an email when new articles are posted on . Adjunctive transdermal testosterone was well tolerated but not more effective than placebo for symptoms of ...

PALM BEACH GARDENS, Fla.--(BUSINESS WIRE)--Transdermal Delivery Solutions Corporation (TDSC) www.TDSC.us announced today the receipt of its releases to begin its pivotal phase of clinical trials. The ...

The use of testosterone as gender-affirming hormone therapy (GAHT) among transgender men is associated with a lower risk for erythrocytosis (abnormal blood cell elevation) than was previously reported ...

Please provide your email address to receive an email when new articles are posted on . High hematocrit levels were observed among 8.4% of adults receiving gender-confirming testosterone therapy.